PyInvesting

Market research

3349.TSE COSMOS Pharmaceutical Corporation

TSE JPY Healthcare

Latest close

— —

Loading market data…

Test a moving-average rule with historical data.

Market facts
Market cap
507B
P/E ratio
15.81
Analyst target
7620
Dividend yield
1.3%
Beta
0.16

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 6 months ago

COSMOS Pharmaceutical Corporation is currently in a long term downtrend where the price is trading 4.1% below its 200 day moving average.

From a valuation standpoint, the stock is 98.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.9.

COSMOS Pharmaceutical Corporation's total revenue rose by 8.9% to $175B since the same quarter in the previous year.

Its net income has increased by 50.0% to $6B since the same quarter in the previous year.

Based on the above factors, COSMOS Pharmaceutical Corporation gets an overall score of 3/5.